Vaccinex sees long term value in building clinical programs that beneficially impact patient care. With that goal in mind, we are building a pipeline of novel candidate therapeutics that we hope will improve upon existing therapies and offer patient treatment options that improve their quality of life. Use the menu on the left to browse our clinical programs.

 

 

Active Clinical Trials

June – 2015 – Huntington’s Disease SIGNAL trial

A Phase 2, multi-center, randomized, double-blinded, placebo-controlled clinical trial in subjects with late prodromal and early manifest Huntington disease (HD) to assess safety, tolerability, pharmacokinetics, and efficacy of VX15/2503

 

Link to clinicaltrials.gov page for this study
Flyer with more information